Kuraji R, Shiba T, Dong T, Numabe Y, Kapila Y
World J Gastroenterol. 2023; 29(6):967-996.
PMID: 36844143
PMC: 9950865.
DOI: 10.3748/wjg.v29.i6.967.
Guo J, Wang P, Cui Y, Hu X, Chen F, Ma C
Nutrients. 2023; 15(4).
PMID: 36839401
PMC: 9959022.
DOI: 10.3390/nu15041043.
Shen S, Wang K, Zhi Y, Dong Y
Pharm Biol. 2022; 60(1):1949-1959.
PMID: 36205541
PMC: 9553138.
DOI: 10.1080/13880209.2022.2126503.
Mare R, Sporea I, Tomescu M, Pop G, Vitel A, Popescu A
Diabetes Metab Syndr Obes. 2022; 15:1703-1713.
PMID: 35698652
PMC: 9188395.
DOI: 10.2147/DMSO.S358744.
Huh Y, Cho Y, Nam G
J Obes Metab Syndr. 2022; 31(1):17-27.
PMID: 35332111
PMC: 8987457.
DOI: 10.7570/jomes22021.
Cumulative Betel Quid Chewing and the Risk of Significant Liver Fibrosis in Subjects With and Without Metabolic Syndrome.
Chou Y, Sun Z, Shen W, Yang Y, Lu F, Chang C
Front Nutr. 2022; 9:765206.
PMID: 35223941
PMC: 8873786.
DOI: 10.3389/fnut.2022.765206.
Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease.
Kani H, Demirtas C, Keklikkiran C, Ergenc I, Mehdiyev S, Akdeniz E
Turk J Gastroenterol. 2021; 32(8):661-666.
PMID: 34528879
PMC: 8975474.
DOI: 10.5152/tjg.2021.20512.
Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
Kuraji R, Sekino S, Kapila Y, Numabe Y
Periodontol 2000. 2021; 87(1):204-240.
PMID: 34463983
PMC: 8456799.
DOI: 10.1111/prd.12387.
Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
Zhang X, Heredia N, Balakrishnan M, Thrift A
PLoS One. 2021; 16(6):e0252164.
PMID: 34081733
PMC: 8174685.
DOI: 10.1371/journal.pone.0252164.
Non-alcoholic fatty liver disease in Africa: a hidden danger.
Paruk I, Pirie F, Motala A
Glob Health Epidemiol Genom. 2019; 4:e3.
PMID: 31019719
PMC: 6465678.
DOI: 10.1017/gheg.2019.2.
Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study.
Chang Y, Noh Y, Suh B, Kim Y, Sung E, Jung H
J Clin Med. 2018; 7(11).
PMID: 30469392
PMC: 6262563.
DOI: 10.3390/jcm7110458.
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.
Stephenson K, Kennedy L, Hargrove L, Demieville J, Thomson J, Alpini G
Gene Expr. 2017; 18(1):5-17.
PMID: 29096730
PMC: 5860971.
DOI: 10.3727/105221617X15093707969658.
Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
Carr R, Patel A, Bownik H, Oranu A, Kerner C, Praestgaard A
Dig Dis Sci. 2017; 62(5):1354-1361.
PMID: 28265826
DOI: 10.1007/s10620-017-4495-0.
Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis.
Stine J, Argo C, Pelletier S, Maluf D, Caldwell S, Northup P
World J Hepatol. 2017; 9(3):139-146.
PMID: 28217250
PMC: 5295147.
DOI: 10.4254/wjh.v9.i3.139.
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.
Sherif Z, Saeed A, Ghavimi S, Nouraie S, Laiyemo A, Brim H
Dig Dis Sci. 2016; 61(5):1214-25.
PMID: 27038448
PMC: 4838529.
DOI: 10.1007/s10620-016-4143-0.
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome.
Wainwright P, Byrne C
Int J Mol Sci. 2016; 17(3):367.
PMID: 26978356
PMC: 4813227.
DOI: 10.3390/ijms17030367.
Phosphatidylethanolamine Metabolism in Health and Disease.
Calzada E, Onguka O, Claypool S
Int Rev Cell Mol Biol. 2016; 321:29-88.
PMID: 26811286
PMC: 4778737.
DOI: 10.1016/bs.ircmb.2015.10.001.
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases.
Raff E, Kakati D, Bloomer J, Shoreibah M, Rasheed K, Singal A
J Clin Transl Hepatol. 2015; 3(1):9-16.
PMID: 26356325
PMC: 4542082.
DOI: 10.14218/JCTH.2015.00001.
Recent advances in understanding/management of non-alcoholic steatohepatitis.
Pacana T, Sanyal A
F1000Prime Rep. 2015; 7:28.
PMID: 25926979
PMC: 4371374.
DOI: 10.12703/P7-28.
Non-alcoholic fatty liver disease: a diabetologist's perspective.
Pappachan J, Antonio F, Edavalath M, Mukherjee A
Endocrine. 2013; 45(3):344-53.
PMID: 24287794
DOI: 10.1007/s12020-013-0087-8.
